Doctoral defense - Gry Sandvik Haaland
Gry Sandvik Haaland defends Friday November 17th 2017 her dissertation “Investigations of the cancer therapeutic and protective effects of warfarin-mediated inhibition of the receptor tyrosine kinase AXL” at the University of Bergen.
Main content
The candidate is from the Department of Biomedicine and CCBIO.
Main supervisor: Professor James Lorens
Co-supervisor: MD and PhD Oddbjørn Straume
Trial lecture: Friday November 17th 2017 at 10.15
Place: Auditorium 1, BB-building, Jonas Lies vei 91
Subject: “The role of Cancer-Associated fibroblasts (CAFs) in tumour progression”
Defense: Friday November 17th 2017 at 12.15
Place: Auditorium 1, BB-building, Jonas Lies vei 91
Dissertation title: “Investigations of the cancer therapeutic and protective effects of warfarin-mediated inhibition of the receptor tyrosine kinase AXL”
1. Opponent: PhD Sassan Hafizi, University of Portsmouth, UK
2. Opponent: Professor Kristin A. Taskén, Oslo University Hospital
3. Member of the Committee: Professor Linda Elin Birkhaug Stuhr, University of Bergen
The defense will be led by Boleslaw Srebro.
Open to the public.
RELATED ARTICLES
Also note news story An old drug may prevent cancer.
Also see press release (in Norwegian only).
